It is of great importance to note that subcutaneously injection of mouse FGF1 or intracerebroventricular injection of human FGF1 can significantly improve the insulin sensitivity and reduce the serum glucose levels in mouse models of diabetes [29]. Here, INS is linked to diabetes mellitus.